Depression News

Among older adults, more time spent being sedentary was significantly associated with a higher incidence of dementia, a study published in JAMA found.

ASCO and Society for Integrative Oncology published a guideline that recommends mindfulness-based interventions and other integrative approaches for management of cancer-related anxiety and depression.

SAN DIEGO — Psilocybin has emerged as a potential treatment for depression and anxiety, including among patients with chronic rheumatic or autoimmune conditions, according to a speaker at the 2023 Congress of Clinical Rheumatology West.

PHILADELPHIA — Patients with a psychotic-spectrum disorder may be more likely to develop Parkinson’s disease, especially if they have an additional diagnosis of anxiety, according to a poster presentation.

Transgender and gender-diverse adolescents reported high menstrual suppression effectiveness and satisfaction, according to a cross-sectional study published in Obstetrics & Gynecology.

An audiovisual-stimulation device improved fibromyalgia symptoms and decreased the use of medications and health care services, according to results of a pilot study presented at PAINWeek.

Users of both tobacco and cannabis were more likely than nonusers to report anxiety and depression, a recent study in PloS One showed.

National Suicide Prevention Month, during September, came this year shortly after the CDC released data pinning 2022 as the all-time high for U.S. suicide deaths, with a total of nearly 50,000.

In patients with symptomatic atrial fibrillation, catheter ablation improved psychological symptoms of anxiety and depression compared with medical therapy, according to results of the REMEDIAL trial.

A single dose of psilocybin resulted in clinically and statistically significant reductions in depressive symptoms and functional disability compared with placebo in patients with major depressive disorder, according to a phase 2 study.